AHPA Modifies Ephedra Petition To Specify Two Chinese Herbals
This article was originally published in The Tan Sheet
The American Herbal Products Association is modifying a petition to stay FDA's ephedra ban by highlighting two Chinese herbal ingredients that the group feels are wrongly included
You may also be interested in...
AHPA has petitioned the FDA to stay its ephedra ban "only insofar as it pertains to traditional herbal formulas" marketed to licensed health care practitioners
A 1final rule prohibiting the sale of dietary supplements containing ephedrine alkaloids will become effective April 12, FDA announced Feb. 6
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC